Vestre Viken Hospital Trust Drammen
Welcome,         Profile    Billing    Logout  
 3 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Froholdt, Anne
NCT03704363: BackToBasic: Infliximab in Chronic Low Back Pain and Modic Changes

Completed
3
128
Europe
Biosimilar Infliximab, Placebo, NaCl intravenous infusion
Oslo University Hospital, Haukeland University Hospital, St. Olavs Hospital, University Hospital of North Norway, Vestre Viken Hospital Trust, Ostfold Hospital Trust, Clinical Trial Unit (CTU), Oslo University Hospital, Diakonhjemmet Hospital
Low Back Pain
07/23
09/23
Matijosaitis, Vaidas
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Terminated
3
535
Europe, Canada, Japan, US, RoW
BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo
Remedy Pharmaceuticals, Inc.
Brain Edema, Stroke, Acute
08/23
08/23
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25
Valalkiene, Jurgita
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25
Nakstad, Ingvild
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25
Bergum, Mette
NeuroCovid, NCT04576351: The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19

Completed
N/A
175
Europe
Observation
Oslo University Hospital, University Hospital, Akershus, Haukeland University Hospital, Helse Stavanger HF, St. Olavs Hospital, University Hospital of North Norway, Vestre Viken Hospital Trust, Sykehuset Telemark, Sykehuset Innlandet HF, Ostfold Hospital Trust, The Hospital of Vestfold, Sorlandet Hospital HF, Nordlandssykehuset HF, Møre og Romsdal Hospital Trust
Covid19
05/23
12/23
Spetalen, Torstein
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25
ELAN, NCT03148457: Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial

Completed
N/A
2013
Europe, Japan, RoW
Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®), Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)
Insel Gruppe AG, University Hospital Bern
Ischaemic Stroke
12/22
05/23

Download Options